JP2018517900A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018517900A5 JP2018517900A5 JP2017557438A JP2017557438A JP2018517900A5 JP 2018517900 A5 JP2018517900 A5 JP 2018517900A5 JP 2017557438 A JP2017557438 A JP 2017557438A JP 2017557438 A JP2017557438 A JP 2017557438A JP 2018517900 A5 JP2018517900 A5 JP 2018517900A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- medium
- stem cells
- tgfβ1
- measuring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000002901 mesenchymal stem cell Anatomy 0.000 claims 17
- 238000000034 method Methods 0.000 claims 17
- 210000004027 cell Anatomy 0.000 claims 11
- 239000002609 medium Substances 0.000 claims 6
- 238000002560 therapeutic procedure Methods 0.000 claims 4
- 239000001963 growth medium Substances 0.000 claims 3
- 238000002965 ELISA Methods 0.000 claims 2
- 206010061246 Intervertebral disc degeneration Diseases 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 2
- 238000012258 culturing Methods 0.000 claims 2
- 208000018180 degenerative disc disease Diseases 0.000 claims 2
- 208000021600 intervertebral disc degenerative disease Diseases 0.000 claims 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims 1
- 241001137251 Corvidae Species 0.000 claims 1
- 230000003213 activating effect Effects 0.000 claims 1
- 230000004913 activation Effects 0.000 claims 1
- 239000007640 basal medium Substances 0.000 claims 1
- 229940098773 bovine serum albumin Drugs 0.000 claims 1
- 230000002648 chondrogenic effect Effects 0.000 claims 1
- KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 claims 1
- 229940099552 hyaluronan Drugs 0.000 claims 1
- 229920002674 hyaluronan Polymers 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 238000005259 measurement Methods 0.000 claims 1
- 238000010899 nucleation Methods 0.000 claims 1
- 210000000130 stem cell Anatomy 0.000 claims 1
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020190850A JP7335222B2 (ja) | 2015-05-05 | 2020-11-17 | 効力検定 |
| JP2023132587A JP7754893B2 (ja) | 2015-05-05 | 2023-08-16 | 効力検定 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2015901605A AU2015901605A0 (en) | 2015-05-05 | Potency assay | |
| AU2015901605 | 2015-05-05 | ||
| PCT/EP2016/060049 WO2016177805A1 (en) | 2015-05-05 | 2016-05-04 | Potency assay |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020190850A Division JP7335222B2 (ja) | 2015-05-05 | 2020-11-17 | 効力検定 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018517900A JP2018517900A (ja) | 2018-07-05 |
| JP2018517900A5 true JP2018517900A5 (enExample) | 2019-06-06 |
| JP6797833B2 JP6797833B2 (ja) | 2020-12-09 |
Family
ID=56087237
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017557438A Active JP6797833B2 (ja) | 2015-05-05 | 2016-05-04 | 効力検定 |
| JP2020190850A Active JP7335222B2 (ja) | 2015-05-05 | 2020-11-17 | 効力検定 |
| JP2023132587A Active JP7754893B2 (ja) | 2015-05-05 | 2023-08-16 | 効力検定 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020190850A Active JP7335222B2 (ja) | 2015-05-05 | 2020-11-17 | 効力検定 |
| JP2023132587A Active JP7754893B2 (ja) | 2015-05-05 | 2023-08-16 | 効力検定 |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US11795435B2 (enExample) |
| EP (2) | EP4015624B1 (enExample) |
| JP (3) | JP6797833B2 (enExample) |
| KR (2) | KR102885856B1 (enExample) |
| CN (2) | CN115141872A (enExample) |
| AU (3) | AU2016258980B2 (enExample) |
| CA (1) | CA2984987C (enExample) |
| ES (2) | ES2911266T3 (enExample) |
| WO (1) | WO2016177805A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20200088445A (ko) | 2017-11-22 | 2020-07-22 | 메조블라스트 인터내셔널 에스에이알엘 | 세포 조성물 및 치료 방법 i |
| WO2020058324A1 (en) * | 2018-09-20 | 2020-03-26 | Citospin, S.L. | Method for obtaining an enriched population of functional mesenchymal stem cells, cells obtained thereof and compositions comprising the same |
| EP3906035A1 (en) * | 2019-01-02 | 2021-11-10 | Mesoblast International Sàrl | Method for treating lower back pain |
| US20230221303A1 (en) * | 2020-04-20 | 2023-07-13 | Longeveron Inc. | Potency assay |
| EP4641205A1 (en) * | 2022-12-23 | 2025-10-29 | Kangstem Biotech Co., Ltd. | Method for selecting stem cells with enhanced cartilage differentiation capability and cell therapy product comprising same |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3089815A (en) | 1951-10-11 | 1963-05-14 | Lieb Hans | Injectable pharmaceutical preparation, and a method of making same |
| US4593089A (en) | 1980-07-30 | 1986-06-03 | Abbott Laboratories | Fluorescent polarization immunoassay utilizing substituted triazinylaminofluorescein aminoglycosides |
| US4751190A (en) | 1985-07-22 | 1988-06-14 | Abbott Laboratories | Fluorescence polarization immunoassay and reagents for use therein |
| US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
| US4983393A (en) | 1987-07-21 | 1991-01-08 | Maximed Corporation | Intra-vaginal device and method for sustained drug release |
| WO1992001070A1 (en) | 1990-07-09 | 1992-01-23 | The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce | High efficiency packaging of mutant adeno-associated virus using amber suppressions |
| US5173414A (en) | 1990-10-30 | 1992-12-22 | Applied Immune Sciences, Inc. | Production of recombinant adeno-associated virus vectors |
| US5486359A (en) | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
| WO1993003769A1 (en) | 1991-08-20 | 1993-03-04 | THE UNITED STATES OF AMERICA, represented by THE SECRETARY, DEPARTEMENT OF HEALTH AND HUMAN SERVICES | Adenovirus mediated transfer of genes to the gastrointestinal tract |
| DE4211351A1 (de) | 1992-04-04 | 1993-10-07 | Behringwerke Ag | Verfahren zur Analyse partikelverstärkter Agglutinationsreaktionen auf Zentrifugalanalysatoren durch Bestimmung der Trübungsaufhellung |
| CA2163129A1 (en) | 1993-05-17 | 1994-11-24 | Flossie Wong-Staal | Ribozyme gene therapy for hiv infection and aids |
| US6541213B1 (en) | 1996-03-29 | 2003-04-01 | University Of Washington | Microscale diffusion immunoassay |
| CA2244326C (en) | 1997-08-11 | 2006-03-28 | Shinichi Eda | Microparticle enhanced light scattering agglutination assay and microparticle reagents therefor |
| CA2360044A1 (en) | 1999-01-15 | 2000-07-20 | Medtox Scientific, Inc. | Lateral flow test strip |
| AU2003901668A0 (en) | 2003-03-28 | 2003-05-01 | Medvet Science Pty. Ltd. | Non-haemopoietic precursor cells |
| AU7362301A (en) | 2000-06-22 | 2002-01-02 | Sam L Austin | Bioadhesive compositions and methods of preparation and use |
| US7205159B2 (en) | 2001-08-20 | 2007-04-17 | Proteome Systems Intellectual Property Pty Ltd. | Diagnostic testing process and apparatus |
| AU2003302132B2 (en) | 2002-11-21 | 2008-02-21 | Inverness Medical Switzerland Gmbh | Bodily fluid markers of tissue hypoxia |
| AU2006235211B2 (en) | 2005-04-12 | 2010-10-14 | Mesoblast, Inc. | Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase |
| KR100802011B1 (ko) | 2005-08-10 | 2008-02-12 | 인하대학교 산학협력단 | 층분리배양법을 이용한 골수에서의 중간엽 줄기세포분리방법 |
| JP2011196840A (ja) * | 2010-03-19 | 2011-10-06 | Univ Of Tokyo | 急性大動脈解離の検査方法 |
| BE1020528A3 (fr) * | 2011-10-11 | 2013-12-03 | Bone Therapeutics Sa | Utilisations du facteur de croissance et differenciation 8 (gdf 8). |
| MX2015015814A (es) | 2013-05-16 | 2016-06-02 | Agency Science Tech & Res | Sulfatos de heparán. |
| KR20150016117A (ko) | 2013-07-30 | 2015-02-11 | 코아스템(주) | 인간 골수 유래 중간엽 줄기세포를 유효성분으로 포함하는 자가면역질환의 예방 또는 치료용 약제학적 조성물 |
| CN103990181B (zh) * | 2014-05-26 | 2015-07-08 | 中国人民解放军第四军医大学 | 一种具有诱导活性微载体-细胞复合物的制备方法及其应用 |
-
2016
- 2016-05-04 CA CA2984987A patent/CA2984987C/en active Active
- 2016-05-04 ES ES16725775T patent/ES2911266T3/es active Active
- 2016-05-04 KR KR1020237032315A patent/KR102885856B1/ko active Active
- 2016-05-04 ES ES22150277T patent/ES3018944T3/es active Active
- 2016-05-04 EP EP22150277.6A patent/EP4015624B1/en active Active
- 2016-05-04 AU AU2016258980A patent/AU2016258980B2/en active Active
- 2016-05-04 JP JP2017557438A patent/JP6797833B2/ja active Active
- 2016-05-04 CN CN202210727621.4A patent/CN115141872A/zh active Pending
- 2016-05-04 CN CN201680030528.0A patent/CN107771220B/zh active Active
- 2016-05-04 EP EP16725775.7A patent/EP3292199B1/en active Active
- 2016-05-04 US US15/571,178 patent/US11795435B2/en active Active
- 2016-05-04 KR KR1020177034098A patent/KR102582602B1/ko active Active
- 2016-05-04 WO PCT/EP2016/060049 patent/WO2016177805A1/en not_active Ceased
-
2020
- 2020-11-17 JP JP2020190850A patent/JP7335222B2/ja active Active
-
2022
- 2022-05-11 AU AU2022203140A patent/AU2022203140B2/en active Active
-
2023
- 2023-08-16 JP JP2023132587A patent/JP7754893B2/ja active Active
- 2023-09-06 US US18/461,866 patent/US20240076621A1/en not_active Abandoned
-
2024
- 2024-08-20 US US18/810,282 patent/US20240409898A1/en active Pending
-
2025
- 2025-07-02 AU AU2025205043A patent/AU2025205043A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ali et al. | Multi-lineage differentiation of human umbilical cord Wharton’s jelly mesenchymal stromal cells mediates changes in the expression profile of stemness markers | |
| JP7506011B2 (ja) | 心筋細胞シート | |
| JP2018517900A5 (enExample) | ||
| Wanjare et al. | Perivascular cells in blood vessel regeneration | |
| Shi et al. | Neural cell adhesion molecule modulates mesenchymal stromal cell migration via activation of MAPK/ERK signaling | |
| GB2432835A (en) | Culturing human embryonic stem cells | |
| JP2019505221A (ja) | ヒト心室前駆細胞の生着のための遺伝子マーカー | |
| JP2020120677A (ja) | ヒト心室前駆体細胞を単離するための細胞表面マーカーとしてのＪａｇｇｅｄ１／Ｆｒｉｚｚｌｅｄ４の使用 | |
| JP2022036183A (ja) | 移植のための臓器の改良 | |
| JP2013504303A (ja) | 肺組織モデル | |
| NZ703122A (en) | Cytokine biomarkers as predictive biomarkers of clinical response for glatiramer acetate | |
| TWI772790B (zh) | 前驅調節滋胚內層細胞及其用途 | |
| CN103261407A (zh) | 用于识别和培养具有高度增殖潜能的多能间充质干细胞的方法 | |
| JP2012514983A5 (enExample) | ||
| Ma et al. | Analysis of differentially expressed microRNA of TNF-α-stimulated mesenchymal stem cells and exosomes from their culture supernatant | |
| Davies et al. | Human cord blood stem cells enhance neonatal right ventricular function in an ovine model of right ventricular training | |
| TW202035682A (zh) | 表現hla-g之肝先驅細胞及取得包含該等細胞之此等細胞組成物之方法與其用途 | |
| Bellu et al. | Isolating stem cells from skin: Designing a novel highly efficient non-enzymatic approach | |
| JP2008289486A5 (enExample) | ||
| Salemi et al. | Differentiated adipose-derived stem cells for bladder bioengineering | |
| Shi et al. | The effect of extended passaging on the phenotype and osteogenic potential of human umbilical cord mesenchymal stem cells | |
| Boheler et al. | Embryonic stem cell‐derived cardiomyocyte heterogeneity and the isolation of immature and committed cells for cardiac remodeling and regeneration | |
| JP2025000600A (ja) | ヒト臍帯間葉系幹細胞シート及びその製造方法 | |
| KR102023805B1 (ko) | 케노데옥시콜산을 이용한 줄기세포 증식능 향상 방법 | |
| JP2022513475A (ja) | Ｈｌａ－ｅを発現する肝臓前駆細胞を含む細胞組成物 |